Estudo randomizado | Plasma convalescente não melhora os desfechos e pode ser prejudicial a pacientes hospitalizados com COVID-19.

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial – Nature Medicine

Comunicado de imprensa: Major study finds convalescent plasma doesn’t help seriously ill COVID-19 patients – McMaster University

Conteúdos relacionados:

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.

M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.

RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.

Comentário no Twitter

A randomized trial in patients hospitalized with COVID-19 showed no benefit and potentially increased harm associated with the use of convalescent plasma, according to a @NatureMedicine paper. https://t.co/7JFhEXLmbA pic.twitter.com/Q3e50Q0I7T

— Nature Portfolio (@NaturePortfolio) September 9, 2021